logo
Former Penny Stock's 54,000% Rise Makes Two Australians Billionaires

Former Penny Stock's 54,000% Rise Makes Two Australians Billionaires

Bloomberg12-06-2025
In 2009, as the global financial crisis rumbled, a little-known Australian health-tech firm snapped up a struggling imaging company for $3.5 million. Today, that bet has turned Pro Medicus Ltd. into a A$29 billion ($19 billion) firm — its shares soaring 54,000% over the past 15 years to outpace even artificial intelligence giant Nvidia Corp.
The rally in the Melbourne-headquartered provider of cloud-based cancer diagnostic software has also vaulted its founders — Sam Hupert and Anthony Hall — into the ranks of the world's richest. Each is now worth about $4.7 billion, according to the Bloomberg Billionaires Index, which is valuing them for the first time.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dollar slips as investors eye September Fed cut
Dollar slips as investors eye September Fed cut

CNBC

time13 minutes ago

  • CNBC

Dollar slips as investors eye September Fed cut

The dollar weakened on Wednesday after a tame reading on U.S. inflation bolstered expectations of a Federal Reserve rate cut next month, with President Donald Trump's attempts to extend his grip over U.S. institutions also undermining the currency. U.S. consumer prices increased marginally in July, data showed on Tuesday, in line with forecasts and as the pass-through from Trump's sweeping tariffs to goods prices has so far been limited. Investors eyeing imminent Fed cuts cheered the data and moved to price in a 98% chance the central bank would ease rates next month, which in turn dragged on the dollar. Against the yen, the dollar was last 0.05% lower at 147.76, while the euro was steady at $1.1676, having risen 0.5% in the previous session. The dollar index last stood at 98.08, after falling roughly 0.5% on Tuesday. "The July CPI report showed less evidence of tariff pass-through to consumer prices...(but) I think a September rate cut is less than certain, probably not as certain as current market pricing," said Carol Kong, a currency strategist at Commonwealth Bank of Australia. "As the last payroll shows, one report can be sufficient to move the policy debate to one side or another. So I think we still have to wait until the remaining data to print before making a strong case about a rate cut or an on hold decision." U.S. Treasury yields similarly fell on the heightened rate cut expectations, with the two-year yield last at 3.7371%, having swung in a range of nearly 10 basis points on Tuesday. The benchmark 10-year yield was little changed at 4.2965%. Also eroding investor confidence in the dollar were fresh attempts by Trump to undermine Fed independence, after White House spokeswoman Karoline Leavitt said on Tuesday that the U.S. president was considering a lawsuit against Fed Chair Jerome Powell in relation to his management of renovations at the central bank's Washington headquarters. Trump has been at loggerheads with Powell and has repeatedly lambasted the Fed Chair for not easing rates sooner. The president also hit out at Goldman Sachs CEO David Solomon, saying the bank had been wrong to predict U.S. tariffs would hurt the economy and questioned whether Solomon should lead the Wall Street institution. Elsewhere, sterling gained 0.03% to $1.3504. Britain's jobs market weakened again though wage growth stayed strong, according to data on Tuesday, underscoring why the Bank of England is so cautious about cutting interest rates. "(The) UK jobs figures pointed to the labor market remaining in fragile shape," said Michael Brown, senior research strategist at Pepperstone. "My base case still has the next 25bp cut penciled in for November, though there is a long way to go, and a lot of data to come, before then." In other currencies, the Australian dollar dipped 0.05% to $0.6526, while the New Zealand dollar fell 0.03% to $0.5953. The Reserve Bank of Australia on Tuesday cut interest rates as expected, and signaled further policy easing might be needed to meet its inflation and employment goals as the economy lost some momentum.

3 ASX Penny Stocks With Market Caps Larger Than A$80M
3 ASX Penny Stocks With Market Caps Larger Than A$80M

Yahoo

time3 hours ago

  • Yahoo

3 ASX Penny Stocks With Market Caps Larger Than A$80M

Australian shares are experiencing a positive trend, with the ASX 200 climbing towards new all-time highs, buoyed by recent decisions from the Reserve Bank. In such an encouraging market environment, identifying stocks that balance affordability with growth potential is key. While 'penny stocks' might seem like a term from another era, they remain relevant for investors seeking opportunities in smaller companies with solid financial foundations and promising prospects. Top 10 Penny Stocks In Australia Name Share Price Market Cap Financial Health Rating Alfabs Australia (ASX:AAL) A$0.41 A$117.5M ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$2.21 A$104.25M ★★★★★★ GTN (ASX:GTN) A$0.39 A$74.36M ★★★★★★ IVE Group (ASX:IGL) A$2.99 A$461M ★★★★★☆ West African Resources (ASX:WAF) A$2.68 A$3.06B ★★★★★★ Regal Partners (ASX:RPL) A$3.00 A$1.01B ★★★★★★ Sugar Terminals (NSX:SUG) A$0.99 A$363.6M ★★★★★★ Austco Healthcare (ASX:AHC) A$0.365 A$133.41M ★★★★★★ CTI Logistics (ASX:CLX) A$1.82 A$146.59M ★★★★☆☆ Reckon (ASX:RKN) A$0.645 A$73.08M ★★★★☆☆ Click here to see the full list of 458 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. Adairs Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Adairs Limited is a specialty retailer offering home furnishings, furniture, and decoration products in Australia and New Zealand, with a market cap of A$387.07 million. Operations: The company's revenue segments comprise A$423.56 million from Adairs, A$125.34 million from Focus, and A$53.57 million from Mocka. Market Cap: A$387.07M Adairs Limited, with a market cap of A$387.07 million, shows mixed prospects as a penny stock. While operating cash flow covers its debt well and it trades at good value compared to peers, short-term and long-term liabilities exceed its assets. The company has experienced negative earnings growth over the past year, though earnings are forecasted to grow by 12.6% annually. Despite having high-quality earnings and no significant shareholder dilution recently, Adairs faces challenges with an inexperienced management team and board. Its net debt to equity ratio is satisfactory, but dividend sustainability remains unstable due to inconsistent payouts. Unlock comprehensive insights into our analysis of Adairs stock in this financial health report. Learn about Adairs' future growth trajectory here. Cogstate Simply Wall St Financial Health Rating: ★★★★★★ Overview: Cogstate Limited is a neuroscience technology company that creates, validates, and commercializes digital brain health assessments for academic and industry-sponsored research, with a market cap of A$302.20 million. Operations: Cogstate generates revenue from two main segments: Healthcare (including Sport), which contributes $2.98 million, and Clinical Trials (including Precision Recruitment Tool & Research), accounting for $44.22 million. Market Cap: A$302.2M Cogstate Limited, with a market cap of A$302.20 million, presents a compelling case in the penny stock segment due to its strong financial fundamentals and recent performance. The company is debt-free, with short-term assets significantly exceeding both short and long-term liabilities. Earnings have grown by 33.3% over the past year, surpassing industry averages, while profit margins have improved from last year. Despite a low return on equity of 16.6%, Cogstate's earnings are expected to grow by 14.58% annually. Recent guidance indicates revenue growth between 20% and 24% for FY25 compared to the previous year. Get an in-depth perspective on Cogstate's performance by reading our balance sheet health report here. Assess Cogstate's future earnings estimates with our detailed growth reports. Integrated Research Simply Wall St Financial Health Rating: ★★★★★★ Overview: Integrated Research Limited specializes in designing, developing, implementing, and selling systems and applications management software for business-critical computing as well as unified communication and payment networks, with a market cap of A$87.79 million. Operations: The company's revenue is primarily generated from its Software & Programming segment, totaling A$71.29 million. Market Cap: A$87.79M Integrated Research Limited, with a market cap of A$87.79 million, offers potential in the penny stock arena due to its recent profitability and robust financial position. The company has no debt, and its short-term assets significantly exceed liabilities. Despite a history of declining earnings over the past five years, Integrated Research became profitable last year and maintains high-quality earnings with a strong return on equity of 22.3%. However, challenges remain as earnings are forecasted to decline by 26.3% annually over the next three years. Recent product enhancements in cloud migration solutions may support future growth prospects. Dive into the specifics of Integrated Research here with our thorough balance sheet health report. Understand Integrated Research's earnings outlook by examining our growth report. Make It Happen Navigate through the entire inventory of 458 ASX Penny Stocks here. Seeking Other Investments? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ADH ASX:CGS and ASX:IRI. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store